• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children.局部涂抹莫匹罗星/次氯酸钠可降低儿童腹膜炎和出口部位感染的发生率。
Clin J Am Soc Nephrol. 2009 Dec;4(12):1939-43. doi: 10.2215/CJN.02770409. Epub 2009 Oct 9.
2
Dialysis: The importance of peritoneal catheter exit-site care.透析:腹膜导管出口部位护理的重要性。
Nat Rev Nephrol. 2010 May;6(5):259-60. doi: 10.1038/nrneph.2010.45.
3
Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.外用洗必泰和莫匹罗星预防新发腹膜透析患者出口处感染的比较
Perit Dial Int. 2017 May-Jun;37(3):266-272. doi: 10.3747/pdi.2016.00257. Epub 2017 Feb 9.
4
Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.与单独使用庆大霉素相比,交替使用莫匹罗星/庆大霉素会增加真菌性腹膜炎的风险——一项随机开放标签对照试验的结果
Perit Dial Int. 2016 May-Jun;36(3):340-6. doi: 10.3747/pdi.2015.00237. Epub 2016 Apr 4.
5
The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.出口部位抗菌蜂蜜与鼻用莫匹罗星预防对腹膜透析相关腹膜炎和出口部位感染的微生物学及结局的影响:蜜罐试验的一项子研究
Perit Dial Int. 2015 Dec;35(7):712-21. doi: 10.3747/pdi.2014.00206. Epub 2015 Jul 29.
6
The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.莫匹罗星预防腹膜透析导管相关感染中金黄色葡萄球菌的有效性。
Adv Perit Dial. 2000;16:257-61.
7
Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.局部用抗生素是否降低腹膜透析患者出口部位感染率和腹膜炎发作率?泛泰晤士河肾脏审计。
J Nephrol. 2012 Sep-Oct;25(5):819-24. doi: 10.5301/jn.5000071.
8
Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.聚维酮碘、莫匹罗星软膏和生理盐水局部应用预防腹膜透析相关感染的比较有效性(COSMO-PD 试验):一项多中心随机、双盲、对照方案。
Trials. 2019 Dec 19;20(1):754. doi: 10.1186/s13063-019-3953-8.
9
A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.一项比较莫匹罗星和多粘菌素 B/杆菌肽三联软膏在腹膜透析患者中应用的随机对照试验:MP3 研究。
Clin J Am Soc Nephrol. 2012 Feb;7(2):297-303. doi: 10.2215/CJN.07970811. Epub 2011 Dec 1.
10
Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.腹膜透析出口处敷料与感染:一项随机对照试验性研究
Perit Dial Int. 2016 Mar-Apr;36(2):135-9. doi: 10.3747/pdi.2014.00195. Epub 2015 Sep 15.

引用本文的文献

1
Peritoneal dialysis-related infections recommendations: 2016 update. What is new?腹膜透析相关感染的建议:2016年更新版。有哪些新内容?
Int Urol Nephrol. 2017 Dec;49(12):2177-2184. doi: 10.1007/s11255-017-1632-9. Epub 2017 Jun 1.
2
Comparing the Effect of Dressing Versus No-dressing on Exit Site Infection and Peritonitis in Chronic Ambulatory Peritoneal Dialysis Patients.比较换药与不换药对慢性非卧床腹膜透析患者出口处感染和腹膜炎的影响。
Adv Biomed Res. 2017 Jan 31;6:5. doi: 10.4103/2277-9175.199263. eCollection 2017.
3
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.国际腹膜透析学会腹膜炎推荐意见:2016年预防与治疗更新版
Perit Dial Int. 2016 Sep 10;36(5):481-508. doi: 10.3747/pdi.2016.00078. Epub 2016 Jun 9.
4
Readmission within 30 days of hospital discharge among children receiving chronic dialysis.儿童接受慢性透析治疗后 30 天内的再入院率。
Clin J Am Soc Nephrol. 2014 Mar;9(3):536-42. doi: 10.2215/CJN.05410513. Epub 2014 Feb 7.
5
Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at Severance Hospital.儿童腹膜透析相关性腹膜炎的转归:首尔峨山医院 25 年经验。
Yonsei Med J. 2013 Jul;54(4):983-9. doi: 10.3349/ymj.2013.54.4.983.
6
Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis.氧氟沙星溶液用于腹膜透析中持续性出口处和隧道感染
Perit Dial Int. 2013 Jan-Feb;33(1):101-2. doi: 10.3747/pdi.2012.00070.
7
Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.小儿腹膜透析患者导管相关感染和腹膜炎预防与治疗的共识指南:2012年更新版
Perit Dial Int. 2012 Jun;32 Suppl 2(Suppl 2):S32-86. doi: 10.3747/pdi.2011.00091.
8
A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.一项比较莫匹罗星和多粘菌素 B/杆菌肽三联软膏在腹膜透析患者中应用的随机对照试验:MP3 研究。
Clin J Am Soc Nephrol. 2012 Feb;7(2):297-303. doi: 10.2215/CJN.07970811. Epub 2011 Dec 1.
9
Peritoneal dialysis in children with end-stage renal disease.儿童终末期肾病的腹膜透析。
Nat Rev Nephrol. 2011 Sep 27;7(11):659-68. doi: 10.1038/nrneph.2011.135.
10
Dialysis: The importance of peritoneal catheter exit-site care.透析:腹膜导管出口部位护理的重要性。
Nat Rev Nephrol. 2010 May;6(5):259-60. doi: 10.1038/nrneph.2010.45.

本文引用的文献

1
Worldwide variation of dialysis-associated peritonitis in children.儿童透析相关性腹膜炎的全球差异
Kidney Int. 2007 Dec;72(11):1374-9. doi: 10.1038/sj.ki.5002523. Epub 2007 Sep 19.
2
Prevention of peritonitis in children receiving peritoneal dialysis.接受腹膜透析的儿童腹膜炎的预防
Pediatr Nephrol. 2007 Apr;22(4):578-85. doi: 10.1007/s00467-006-0375-0. Epub 2007 Jan 10.
3
Excerpts from the United States Renal Data System 2006 Annual Data Report.美国肾脏数据系统2006年年报摘录。
Am J Kidney Dis. 2007 Jan;49(1 Suppl 1):A6-7, S1-296. doi: 10.1053/j.ajkd.2006.11.019.
4
Exit-site care in peritoneal dialysis.腹膜透析的出口处护理
Contrib Nephrol. 2007;154:117-124. doi: 10.1159/000096955.
5
A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD.一项针对日本接受腹膜透析的儿童腹膜炎及出口处和/或隧道感染情况的调查。
Pediatr Nephrol. 2006 Jun;21(6):828-34. doi: 10.1007/s00467-006-0004-y. Epub 2006 Apr 14.
6
Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.局部应用莫匹罗星对印度腹膜透析人群出口处感染和腹膜炎的影响。
Perit Dial Int. 2005 Sep-Oct;25(5):473-7.
7
Risk factors for peritonitis in pediatric peritoneal dialysis: a single-center study.小儿腹膜透析腹膜炎的危险因素:一项单中心研究。
Pediatr Nephrol. 2005 Oct;20(10):1478-83. doi: 10.1007/s00467-005-1953-2. Epub 2005 Aug 5.
8
The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital.莫匹罗星局部用药对新加坡总医院腹膜透析感染的影响。
Nephrol Dial Transplant. 2005 Oct;20(10):2202-6. doi: 10.1093/ndt/gfi010. Epub 2005 Jul 26.
9
Peritoneal dialysis-related infections recommendations: 2005 update.腹膜透析相关感染的建议:2005年更新版
Perit Dial Int. 2005 Mar-Apr;25(2):107-31.
10
Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.抗生素出口处乳膏预防腹膜透析患者出口处感染的随机双盲试验。
J Am Soc Nephrol. 2005 Feb;16(2):539-45. doi: 10.1681/ASN.2004090773. Epub 2004 Dec 29.

局部涂抹莫匹罗星/次氯酸钠可降低儿童腹膜炎和出口部位感染的发生率。

Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children.

机构信息

Department of Pediatrics, Renal Division, Houston, TX 77030, USA.

出版信息

Clin J Am Soc Nephrol. 2009 Dec;4(12):1939-43. doi: 10.2215/CJN.02770409. Epub 2009 Oct 9.

DOI:10.2215/CJN.02770409
PMID:19820132
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2798867/
Abstract

BACKGROUND AND OBJECTIVES

Peritoneal dialysis (PD) is a common maintenance renal replacement modality for children with ESRD frequently compromised by infectious peritonitis and catheter exit site and tunnel infections (ESI/TI). The effect of topical mupirocin (Mup) and sodium hypochlorite (NaOCl) solution was evaluated as part of routine daily exit site care on peritonitis and ESI/TI rates, causative microorganisms, and catheter survival rates.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Retrospective chart review of children on home continuous cycling PD between April 1, 2001 and June 30, 2007 was performed. Infection rates were examined based on exit site protocol used in two different periods: Mup alone, April 1, 2001 to November 17, 2004; and Mup and NaOCl (Mup+NaOCl), November 18, 2004 to June 30, 2007.

RESULTS

Eighty-three patients (mean PD initiation age: 12.1 +/- 5.8 yr) received home PD over 2009 patient months. Annualized rates (ARs) for peritonitis decreased from 1.2 in the Mup period to 0.26 in the Mup+NaOCl period (P < 0.0001). ARs for ESI/TI decreased from 1.36 in the Mup period to 0.33 in the Mup+NaOCl period (P < 0.0001). No infections with Mup-resistant organisms were observed when either Mup or Mup+NaOCl was used for prophylaxis. Gram-negative-organism associated peritonitis decreased from an AR of 0.31 in the Mup period to 0.07 in the Mup+NaOCl period (P < 0.001). Infection-related catheter removal rates decreased from 1 in 38.9 catheter-months in the Mup period to 1 in 94.2 in the Mup+NaOCl period (P = 0.01). Catheter survival rates were longer in the Mup+NaOCl period (Kaplan-Meier, P < 0.009).

CONCLUSIONS

The combination Mup+NaOCl in daily exit site care was very effective to reduce PD catheter-associated infections and prolong catheter survival in pediatric patients.

摘要

背景与目的

腹膜透析(PD)是儿童终末期肾衰竭的常见维持性肾脏替代方式,常因感染性腹膜炎和导管出口部位及隧道感染(ESI/TI)而受到影响。评估局部莫匹罗星(Mup)和次氯酸钠(NaOCl)溶液作为日常出口部位护理的一部分,对腹膜炎和 ESI/TI 发生率、病原体和导管生存率的影响。

设计、设置、参与者和测量:对 2001 年 4 月 1 日至 2007 年 6 月 30 日期间接受家庭连续循环 PD 的儿童进行回顾性图表审查。根据两种不同时期使用的出口部位方案检查感染率:单独使用 Mup(2001 年 4 月 1 日至 2004 年 11 月 17 日);和 Mup+NaOCl(Mup+NaOCl)(2004 年 11 月 18 日至 2007 年 6 月 30 日)。

结果

83 名患者(PD 起始年龄平均:12.1 +/- 5.8 岁)接受家庭 PD 治疗,共 2009 个患者月。腹膜炎的年发生率(AR)从 Mup 期的 1.2 降至 Mup+NaOCl 期的 0.26(P < 0.0001)。ESI/TI 的 AR 从 Mup 期的 1.36 降至 Mup+NaOCl 期的 0.33(P < 0.0001)。当使用 Mup 或 Mup+NaOCl 进行预防时,均未观察到对 Mup 耐药的生物体感染。革兰氏阴性菌相关腹膜炎的 AR 从 Mup 期的 0.31 降至 Mup+NaOCl 期的 0.07(P < 0.001)。与感染相关的导管去除率从 Mup 期的每 38.9 个导管月 1 例降至 Mup+NaOCl 期的每 94.2 个导管月 1 例(P = 0.01)。Mup+NaOCl 期间导管生存率更长(Kaplan-Meier,P < 0.009)。

结论

在日常出口部位护理中,Mup+NaOCl 的联合使用可有效降低儿科患者 PD 导管相关感染和延长导管生存时间。